Abstract
Purpose/Objective: The increase in life expectancy leads to an increased number of elderly patients (pts) diagnosed with NSCLC. Octogenarians can be a treatment challenge due to frailty and comorbidity. Stereotactic Body Radiotherapy (SBRT) has become the standard treatment for medical inoperable pts with early stage NSCLC. However, it is unknown if all pts have same benefit of SBRT due to lack of randomized studies. This retrospective single-institution study reports survival and control rates for medical inoperable octogenarians vs. pts 80 and 80 and 137 were 80 and 0.05). No difference in comorbidity measured by Charlson Score Index was observed. SBRT was generally well tolerated. A log rank test showed a significant difference of OS between patients >80 and 80 and 80 and
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | PO-0764 |
| Tidsskrift | Radiotherapy & Oncology |
| Vol/bind | 115 |
| Udgave nummer | S1 |
| Sider (fra-til) | S378-S379 |
| ISSN | 0167-8140 |
| DOI | |
| Status | Udgivet - 2015 |
| Begivenhed | 3rd ESTRO Forum - Barcelona, Spanien Varighed: 24. apr. 2015 → 28. apr. 2015 |
Konference
| Konference | 3rd ESTRO Forum |
|---|---|
| Land/Område | Spanien |
| By | Barcelona |
| Periode | 24/04/2015 → 28/04/2015 |
Emneord
- *very elderly *human *patient *stereotactic body radiation therapy survival prognosis proportional hazards model diagnosis comorbidity follow up recurrence free survival life expectancy overall survival survival rate log rank test positron emission tomography staging histology radiation dose smoking population hospital patient neoplasm aged surgery female